News

Investigating Shareholder Claims: A Guide for Investors

Investigating Shareholder Claims: A Guide for Investors

Introduction to Shareholder Investigations

As an investor, being informed about the companies you invest in is crucial. Recently, several firms have found themselves at the center of investigations that could have significant implications for their shareholders. This article sheds light on investor rights and what they can do in the face of potential corporate mismanagement.

Applied Therapeutics, Inc. (NASDAQ: APLT)

Investigation Overview: Grabar Law Office is actively investigating claims on behalf of shareholders of Applied Therapeutics, Inc. The focus of this inquiry is whether the leadership of the company has failed to uphold their fiduciary responsibilities.

A class action concerning securities fraud against Applied Therapeutics has recently reached a settlement. If you are a shareholder who purchased applied Therapeutics shares before January 3, 2024, and you still retain ownership, you have the opportunity to pursue corporate reforms and the potential for financial compensation at no personal cost.

The Allegations

The investigation stems from allegations that certain officers within Applied Therapeutics made false statements to investors about their Phase III INSPIRE trial, concealing critical issues that affected the study's validity. Misleading information led to shareholders purchasing securities at inflated prices.

DoubleVerify Holdings, Inc. (NYSE: DV)

Investigation Status: Similar to APLT, DoubleVerify is also under scrutiny. Grabar Law Office is looking into whether its directors and officers have breached their fiduciary duties.

If you have held DoubleVerify shares since before November 10, 2023, and want to know more about your legal options, it is essential to seek information on your rights and potential recourse.

Concerns Raised

Claims have been made that DoubleVerify did not disclose significant operational challenges, particularly about customer spending shifts, leading to misrepresentations about their financial health. Such oversights mean shareholders could have been misled regarding the company's true performance.

Elevance Health Inc. (NYSE: ELV)

Current Investigations: Elevance Health is under investigation by Grabar Law Office for similar reasons. The inquiry delves into whether its top management has adequately served the interests of shareholders.

Shareholders who purchased Elevance Health shares before April 18, 2024, are encouraged to engage with the ongoing investigation as the findings could impact financial outcomes for long-term investors.

Allegations and Impact

Recent purported claims suggest that Elevance misrepresented its cost trend management practices. This inadequate disclosure may have misled investors regarding the potential costs associated with Medicaid programs, leading to underestimations of the financial challenges faced by the company.

V.F. Corp. (NYSE: VFC)

Investigation Overview: Grabar Law Office is also probing V.F. Corp. for possible breaches of fiduciary duty by its management. This raises concerns about whether the company's executives acted in the interests of its shareholders.

If you acquired V.F. Corp. shares prior to October 30, 2023, or even between October 30, 2023, and May 20, 2025, you may wish to explore your options related to this investigation.

Understanding the Allegations

The core issue lies in allegations that V.F. Corp. shared misleading claims about its strategies to revitalize the Vans brand. Assertions about progress were made even as the brand struggled with declining sales—a situation that inevitably raised questions about the company’s transparency with its investors.

What Should Shareholders Do?

For shareholders of Applied Therapeutics, DoubleVerify, Elevance Health, and V.F. Corp., understanding your rights and options is paramount. Here are steps that shareholders should consider:

  • Stay informed about the ongoing investigations and their outcomes.
  • Contact Grabar Law Office for personalized advice regarding potential remedies.
  • Remain engaged with company announcements and financial disclosures to better understand your investments.
  • Consider joining efforts that advocate for corporate accountability.

Frequently Asked Questions

1. What is a shareholder investigation?

A shareholder investigation examines potential misconduct by company executives that may harm the company or its shareholders.

2. How does one benefit from joining a shareholder lawsuit?

Shareholders may receive compensation or support corporate governance reforms that protect their interests.

3. What should I do if I bought shares in one of these companies?

Contact a legal professional to explore your rights and options based on your purchase date and the current investigations.

4. Are there any costs involved in joining the investigations?

No, these investigations typically don't require out-of-pocket costs from shareholders.

5. How can I stay updated on the investigations?

Regularly check legal websites or follow news related to the companies for updates on the ongoing investigations.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Zunyi’s History Tour Carries China’s Story Overseas

Updated Category News Views 75

China’s national story does not travel overseas by accident; it gets carried by visitors, monuments, rail lines, rivers and carefully chosen questions. The Zunyi News and Media Center report follows Tayyab, a Pakistani PhD student in aerospace engineering at Peking University, as he heads from Beijing to Zunyi, Guizhou, carrying a copy of Edgar Snow’s Red Star Over...

Continue Reading
Marelli’s Two Awards Put Practical Auto Tech in Focus

Updated Category News Views 22

Two trophies in Novi do not fill an order book, but Marelli’s latest pair says something useful about where automotive suppliers are trying to earn their keep. The company collected a 2026 Automotive News PACE Award for HorizonView and a PACE Pilot Award for Affordable 5G RedCap at the November 17 ceremony. One is already deployed in production; the other is a...

Continue Reading
Texas Community Bancshares Adds a Special Dividend

Updated Category News Views 109

Nine cents is the whole message—for the moment Texas Community Bancshares has put a little extra cash on the table, declaring a regular quarterly dividend of $0.06 per common share and a special cash dividend of $0.03 per share. Together, holders get $0.09 per share, payable on or about December 15, 2026, provided they are shareholders of record when business closes on...

Continue Reading
Leqembi’s Real-World Data Gives BioArctic More Weight

Updated Category News Views 79

A Harder Look at Treatment Staying Power Alzheimer’s drug data rarely arrive without a thicket of caveats, and that is exactly why this Leqembi update deserves a calm read rather than a victory lap. BioArctic’s partner Eisai presented a three-year real-world analysis at CTAD 2026 covering 560 early Alzheimer’s patients across 13 U.S. sites. The headline is striking:...

Continue Reading
Perform.AI Tests Whether Stores Can Sell to Agents

Updated Category News Views 39

Shopping bots are about to become one more fussy customer standing in the aisle, except this one reads machine-facing files, rejects broken checkout steps, and does not care how pretty the homepage looks. Perform.AI has launched a free UCP and ACP Readiness Checker aimed at online retailers that need to know whether AI agents can find products, purchase them, and follow...

Continue Reading
Villa Group’s Punta Mita Bet Adds 305 Luxury Resort Keys

Updated Category News Views 102

A 12.6-acre slice of Riviera Nayarit coastline is about to get a very expensive makeover, assuming The Villa Group can turn a handsome plan into a functioning resort without the usual development headaches. The company says it has acquired a beachfront parcel in Litibú and intends to build Villa La Valencia Punta Mita, a 305-accommodation luxury property aimed squarely...

Continue Reading
ASUS Brings AI Infrastructure Choices to SC26 Floor

Updated Category News Views 320

Compute buyers are sick of being handed one locked box That is the nerve ASUS is pressing at SC26: enterprises want AI infrastructure that fits the job in front of them, not somebody else's tidy product roadmap. The company is pitching a full-stack “AI Factory” blueprint built across Intel, AMD and NVIDIA hardware, running from rack-scale systems and conventional...

Continue Reading
Pacific Surfliner Faces Thanksgiving Capacity Test

Updated Category News Views 35

Thanksgiving traffic on Southern California freeways is its own yearly punishment, and the Pacific Surfliner is making a sensible pitch: leave the car parked and let the coast roll past the window. For travelers, that can be a real relief. For anyone watching public transportation, this is also a useful little stress test of whether a busy state-supported rail corridor...

Continue Reading
DocLinq Takes Aim at Care Gaps Between Office Visits

Updated Category News Views 0

Healthcare's most expensive loose ends often pile up after the appointment ends. DocLinq, launched from Columbia, Maryland, is taking a run at that awkward stretch between office visits, where records sit in separate systems, chronic-care follow-up gets uneven, and patients are expected to remember far more than any human reasonably can. This is not a story about AI...

Continue Reading
New Flight Charters Puts a Cap on Winter Surprises

Updated Category News Views 255

Ice on a wing is routine; ice on an invoice is where charter customers start muttering. New Flight Charters says it will again absorb de-icing and hangar charges this winter, up to $2,500 per trip, marking the seventh consecutive season for the program. In a business where the headline quote can look tidy and the final bill can arrive wearing muddy boots, that is a...

Continue Reading

Top 5 Most Recently Viewed Articles

Unisys to Engage with Investors at Sidoti Conference Soon

Updated Category News Views 137

Unisys to Connect with Investors at Sidoti Conference Soon Unisys (NYSE: UIS), a leader in technology solutions, is preparing to participate in the upcoming Sidoti Small-Cap Conference. This virtual event allows investors to hear directly from the company's executives, offering valuable insights. Meet with Unisys Executives The conference provides a fantastic chance for...

Continue Reading
VedaBio Welcomes Randy Rasmussen to Board of Directors

Updated Category News Views 341

VedaBio, a key player in biotechnology, took a bold step back in 2024 by appointing Randy Rasmussen, Ph.D., to its Board of Directors. This wasn’t just a casual hire; it’s an infusion of over 30 years of expertise into their operation. With Dr. Rasmussen at the helm, the chatter on the trading floor picked up—everyone was eyeing how this could reshape VedaBio's...

Continue Reading
Acuity Brands Sets Date for Fiscal 2025 First-Quarter Release

Updated Category News Views 99

Acuity Brands to Release Fiscal 2025 First-Quarter Results Acuity Brands, Inc. (NYSE: AYI) has announced an important date for investors and stakeholders. The company will release its fiscal 2025 first-quarter results on a Thursday morning, signaling its ongoing commitment to transparency and communication with its shareholders. Details of the Upcoming Announcement The...

Continue Reading
NV5 Global Successfully Secures Approval for Merger Deal

Updated Category News Views 166

NV5 Global Secures Stockholder Approval for Merger with Acuren Recently, NV5 Global, Inc. (NASDAQ: NVEE), a prominent provider of technology-driven engineering, testing, inspection, and consulting services, announced a major milestone. A significant majority of its stockholders voted in favor of the merger with Acuren Corporation, showcasing strong support for this...

Continue Reading
Why MacBook Users Shouldn't Worry About EU's USB-C Directive

Updated Category News Views 395

Understanding the New EU USB-C Directive The recent implementation of the EU’s USB-C directive has stirred discussions among electronics users, particularly MacBook owners. Effective from 2025, this directive mandates that mobile devices, including smartphones and tablets, must incorporate a USB-C port for charging. The significance of this directive extends beyond just...

Continue Reading